DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Protagonist Therapeutics Q4 EPS $(0.63) Beats $(0.65) Estimate, Sales $2.719M Miss $3.22M Estimate

Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.65) by 3.08 percent. This is a 10.53 percent decrease over losses of $(0.57) per

Benzinga · 03/10/2020 20:01

Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.65) by 3.08 percent. This is a 10.53 percent decrease over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $2.719 million which missed the analyst consensus estimate of $3.22 million by 15.56 percent. This is a 15.55 percent increase over sales of $2.353 million the same period last year.